Ecopipam reduces relapse risk in pediatric Tourette syndrome
1. Ecopipam is a first-in-class investigational selective dopamine D1 receptor antagonist under priority review for pediatric Tourette syndrome, offering a ...
Tag: Tourette Syndrome
2MM: Pharma Roundup – mRNA flu vaccine debuts, RAS inhibition extends pancreatic cancer survival, and new therapies advance for dermatomyositis and Tourette syndrome
mFlusiva outperforms standard-dose flu vaccine in adults 50 and older The U.S. Food and Drug Administration (FDA) approved mFlusiva (mRNA-1010) ...
Ecopipam reduces tics in children with Tourette syndrome
1. In a phase 2 trial of patients with Tourette syndrome, ecopipam, a selective dopamine receptor antagonist, was associated with a ...
No significant differences in efficacy and safety between deutetrabenazine and placebo for the treatment of tics in Tourette syndrome in the pediatric population
1. No significant differences in tic severity were found between deutetrabenazine and placebo after 8 weeks of treatment, despite a ...
Quick Take: Association of Tourette Syndrome and Chronic Tic Disorder With Metabolic and Cardiovascular Disorders
Individuals with Tourette syndrome (TS) and other chronic tic disorders (CTD) are at an increased of developing cardiometabolic disorders, in ...
2 Minute Medicine Rewind January 21, 2019
Association of Tourette Syndrome and Chronic Tic Disorder With Metabolic and Cardiovascular Disorders Individuals with Tourette syndrome (TS) and other ...
Patient Basics: Tourette Syndrome
Originally published by Harvard Health. What Is It? Tourette syndrome (TS) is a problem of the nervous system that was ...
